Highlights
The global Plasmid market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Plasmid is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Plasmid is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Plasmid in Transfection is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Plasmid include Aldevron, GenScript, PlasmidFactory GmbH & Co. KG, VGXI Inc., Oxford Genetics Ltd., Applied StemCell, Altogen Biosystems, Cobra Biologics and Copernicus Therapeutics Inc., etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Plasmid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasmid.
The Plasmid market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Plasmid market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plasmid companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Aldevron
GenScript
PlasmidFactory GmbH & Co. KG
VGXI Inc.
Oxford Genetics Ltd.
Applied StemCell
Altogen Biosystems
Cobra Biologics
Copernicus Therapeutics Inc.
Takara Bio
InvivoGen
Miltenyi Biotec
Medigene Sdn Bhd
MaxCyte Inc.
Mirus Bio LLC
MolMed S.p.A.
GenePharma
Polyplus Transfection
Segment by Type
F-Plasmids
Col Plasmids
Resistance Plasmids
Cryptic Plasmids
Degradative Plasmids
Virulence Plasmids
Segment by Application
Transfection
Recombinant DNA Technology
Gene Therapy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plasmid companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasmid Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 F-Plasmids
1.2.3 Col Plasmids
1.2.4 Resistance Plasmids
1.2.5 Cryptic Plasmids
1.2.6 Degradative Plasmids
1.2.7 Virulence Plasmids
1.3 Market by Application
1.3.1 Global Plasmid Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Transfection
1.3.3 Recombinant DNA Technology
1.3.4 Gene Therapy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Plasmid Market Perspective (2018-2029)
2.2 Plasmid Growth Trends by Region
2.2.1 Global Plasmid Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Plasmid Historic Market Size by Region (2018-2023)
2.2.3 Plasmid Forecasted Market Size by Region (2024-2029)
2.3 Plasmid Market Dynamics
2.3.1 Plasmid Industry Trends
2.3.2 Plasmid Market Drivers
2.3.3 Plasmid Market Challenges
2.3.4 Plasmid Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasmid Players by Revenue
3.1.1 Global Top Plasmid Players by Revenue (2018-2023)
3.1.2 Global Plasmid Revenue Market Share by Players (2018-2023)
3.2 Global Plasmid Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Plasmid Revenue
3.4 Global Plasmid Market Concentration Ratio
3.4.1 Global Plasmid Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasmid Revenue in 2022
3.5 Plasmid Key Players Head office and Area Served
3.6 Key Players Plasmid Product Solution and Service
3.7 Date of Enter into Plasmid Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasmid Breakdown Data by Type
4.1 Global Plasmid Historic Market Size by Type (2018-2023)
4.2 Global Plasmid Forecasted Market Size by Type (2024-2029)
5 Plasmid Breakdown Data by Application
5.1 Global Plasmid Historic Market Size by Application (2018-2023)
5.2 Global Plasmid Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Plasmid Market Size (2018-2029)
6.2 North America Plasmid Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Plasmid Market Size by Country (2018-2023)
6.4 North America Plasmid Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Plasmid Market Size (2018-2029)
7.2 Europe Plasmid Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Plasmid Market Size by Country (2018-2023)
7.4 Europe Plasmid Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plasmid Market Size (2018-2029)
8.2 Asia-Pacific Plasmid Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Plasmid Market Size by Region (2018-2023)
8.4 Asia-Pacific Plasmid Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Plasmid Market Size (2018-2029)
9.2 Latin America Plasmid Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Plasmid Market Size by Country (2018-2023)
9.4 Latin America Plasmid Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasmid Market Size (2018-2029)
10.2 Middle East & Africa Plasmid Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Plasmid Market Size by Country (2018-2023)
10.4 Middle East & Africa Plasmid Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aldevron
11.1.1 Aldevron Company Detail
11.1.2 Aldevron Business Overview
11.1.3 Aldevron Plasmid Introduction
11.1.4 Aldevron Revenue in Plasmid Business (2018-2023)
11.1.5 Aldevron Recent Development
11.2 GenScript
11.2.1 GenScript Company Detail
11.2.2 GenScript Business Overview
11.2.3 GenScript Plasmid Introduction
11.2.4 GenScript Revenue in Plasmid Business (2018-2023)
11.2.5 GenScript Recent Development
11.3 PlasmidFactory GmbH & Co. KG
11.3.1 PlasmidFactory GmbH & Co. KG Company Detail
11.3.2 PlasmidFactory GmbH & Co. KG Business Overview
11.3.3 PlasmidFactory GmbH & Co. KG Plasmid Introduction
11.3.4 PlasmidFactory GmbH & Co. KG Revenue in Plasmid Business (2018-2023)
11.3.5 PlasmidFactory GmbH & Co. KG Recent Development
11.4 VGXI Inc.
11.4.1 VGXI Inc. Company Detail
11.4.2 VGXI Inc. Business Overview
11.4.3 VGXI Inc. Plasmid Introduction
11.4.4 VGXI Inc. Revenue in Plasmid Business (2018-2023)
11.4.5 VGXI Inc. Recent Development
11.5 Oxford Genetics Ltd.
11.5.1 Oxford Genetics Ltd. Company Detail
11.5.2 Oxford Genetics Ltd. Business Overview
11.5.3 Oxford Genetics Ltd. Plasmid Introduction
11.5.4 Oxford Genetics Ltd. Revenue in Plasmid Business (2018-2023)
11.5.5 Oxford Genetics Ltd. Recent Development
11.6 Applied StemCell
11.6.1 Applied StemCell Company Detail
11.6.2 Applied StemCell Business Overview
11.6.3 Applied StemCell Plasmid Introduction
11.6.4 Applied StemCell Revenue in Plasmid Business (2018-2023)
11.6.5 Applied StemCell Recent Development
11.7 Altogen Biosystems
11.7.1 Altogen Biosystems Company Detail
11.7.2 Altogen Biosystems Business Overview
11.7.3 Altogen Biosystems Plasmid Introduction
11.7.4 Altogen Biosystems Revenue in Plasmid Business (2018-2023)
11.7.5 Altogen Biosystems Recent Development
11.8 Cobra Biologics
11.8.1 Cobra Biologics Company Detail
11.8.2 Cobra Biologics Business Overview
11.8.3 Cobra Biologics Plasmid Introduction
11.8.4 Cobra Biologics Revenue in Plasmid Business (2018-2023)
11.8.5 Cobra Biologics Recent Development
11.9 Copernicus Therapeutics Inc.
11.9.1 Copernicus Therapeutics Inc. Company Detail
11.9.2 Copernicus Therapeutics Inc. Business Overview
11.9.3 Copernicus Therapeutics Inc. Plasmid Introduction
11.9.4 Copernicus Therapeutics Inc. Revenue in Plasmid Business (2018-2023)
11.9.5 Copernicus Therapeutics Inc. Recent Development
11.10 Takara Bio
11.10.1 Takara Bio Company Detail
11.10.2 Takara Bio Business Overview
11.10.3 Takara Bio Plasmid Introduction
11.10.4 Takara Bio Revenue in Plasmid Business (2018-2023)
11.10.5 Takara Bio Recent Development
11.11 InvivoGen
11.11.1 InvivoGen Company Detail
11.11.2 InvivoGen Business Overview
11.11.3 InvivoGen Plasmid Introduction
11.11.4 InvivoGen Revenue in Plasmid Business (2018-2023)
11.11.5 InvivoGen Recent Development
11.12 Miltenyi Biotec
11.12.1 Miltenyi Biotec Company Detail
11.12.2 Miltenyi Biotec Business Overview
11.12.3 Miltenyi Biotec Plasmid Introduction
11.12.4 Miltenyi Biotec Revenue in Plasmid Business (2018-2023)
11.12.5 Miltenyi Biotec Recent Development
11.13 Medigene Sdn Bhd
11.13.1 Medigene Sdn Bhd Company Detail
11.13.2 Medigene Sdn Bhd Business Overview
11.13.3 Medigene Sdn Bhd Plasmid Introduction
11.13.4 Medigene Sdn Bhd Revenue in Plasmid Business (2018-2023)
11.13.5 Medigene Sdn Bhd Recent Development
11.14 MaxCyte Inc.
11.14.1 MaxCyte Inc. Company Detail
11.14.2 MaxCyte Inc. Business Overview
11.14.3 MaxCyte Inc. Plasmid Introduction
11.14.4 MaxCyte Inc. Revenue in Plasmid Business (2018-2023)
11.14.5 MaxCyte Inc. Recent Development
11.15 Mirus Bio LLC
11.15.1 Mirus Bio LLC Company Detail
11.15.2 Mirus Bio LLC Business Overview
11.15.3 Mirus Bio LLC Plasmid Introduction
11.15.4 Mirus Bio LLC Revenue in Plasmid Business (2018-2023)
11.15.5 Mirus Bio LLC Recent Development
11.16 MolMed S.p.A.
11.16.1 MolMed S.p.A. Company Detail
11.16.2 MolMed S.p.A. Business Overview
11.16.3 MolMed S.p.A. Plasmid Introduction
11.16.4 MolMed S.p.A. Revenue in Plasmid Business (2018-2023)
11.16.5 MolMed S.p.A. Recent Development
11.17 GenePharma
11.17.1 GenePharma Company Detail
11.17.2 GenePharma Business Overview
11.17.3 GenePharma Plasmid Introduction
11.17.4 GenePharma Revenue in Plasmid Business (2018-2023)
11.17.5 GenePharma Recent Development
11.18 Polyplus Transfection
11.18.1 Polyplus Transfection Company Detail
11.18.2 Polyplus Transfection Business Overview
11.18.3 Polyplus Transfection Plasmid Introduction
11.18.4 Polyplus Transfection Revenue in Plasmid Business (2018-2023)
11.18.5 Polyplus Transfection Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Aldevron
GenScript
PlasmidFactory GmbH & Co. KG
VGXI Inc.
Oxford Genetics Ltd.
Applied StemCell
Altogen Biosystems
Cobra Biologics
Copernicus Therapeutics Inc.
Takara Bio
InvivoGen
Miltenyi Biotec
Medigene Sdn Bhd
MaxCyte Inc.
Mirus Bio LLC
MolMed S.p.A.
GenePharma
Polyplus Transfection
听
听
*If Applicable.